Literature DB >> 23861308

Effect of drug treatment options on the mobility and expression of blaKPC.

Amanda L Roth1, Philip D Lister, Nancy D Hanson.   

Abstract

OBJECTIVES: Both transposition and increases in gene expression have been implicated in the success of KPC-producing pathogens, but the stimulus required for these phenomena are unknown. It is possible that exposure to antimicrobials during patient treatment increases bla(KPC) expression or induces Tn4401 transposition. The purpose of this study was to determine if exposure to carbapenems or other antimicrobial drug classes could stimulate expression of bla(KPC) or the in vitro transposition of Tn4401.
METHODS: Five KPC-producing clinical isolates were evaluated in this study. Gene expression of RNA from each isolate exposed to subinhibitory, MIC or suprainhibitory levels of antibiotics was evaluated using real-time RT-PCR. Southern blots were performed on plasmids from isolates exposed to subinhibitory levels of antibiotics.
RESULTS: There were subtle changes in bla(KPC) RNA expression following antibiotic exposure that were both strain and drug dependent. Multiple plasmids ranging from ~8 to >200 kb were observed for the Enterobacteriaceae isolates, whereas the Pseudomonas aeruginosa isolate had one ~55 kb plasmid. No changes in hybridization patterns or binding intensity for the bla(KPC) probe were observed after antibiotic exposure.
CONCLUSIONS: While the changes in bla(KPC) RNA expression are subtle, the different responses observed suggest both strain- and genera-specific variations in response to different antibiotic treatments.

Entities:  

Keywords:  KPC; Tn4401; collateral damage

Mesh:

Substances:

Year:  2013        PMID: 23861308     DOI: 10.1093/jac/dkt280

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  1 in total

1.  High-performance method to detection of Klebsiella pneumoniae Carbapenemase in Enterobacterales by LC-MS/MS.

Authors:  Otávio A Lovison; Renata B Rau; Daiana Lima-Morales; Evellyn K Almeida; Marina N Crispim; Fabiano Barreto; Afonso L Barth; Andreza F Martins
Journal:  Braz J Microbiol       Date:  2020-01-27       Impact factor: 2.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.